Top

Published in:

01-02-2020 | Chlorthalidone | Clinical study

Chlorthalidone, hydrochlorothiazide cardiovascular outcomes and safety

Published in: Reactions Weekly | Issue 1/2020

Excerpt

In patients with hypertension requiring thiazide diuretic treatment, there do not appear to be cardiovascular benefits with the use of chlorthalidone rather than hydrochlorothiazide, according to study results reported in JAMA Internal Medicine, and chlorthalidone "was associated with greater risk of renal and electrolyte abnormalities". …

Large-Scale Evidence Generation and Evaluation in a Network of Databases

Hripcsak G, et al. Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension. JAMA Internal Medicine : 17 Feb 2020. Available from: URL: http://dx.doi.org/10.1001/jamainternmed.2019.7454

Title: Chlorthalidone, hydrochlorothiazide cardiovascular outcomes and safety
Publication date: 01-02-2020
Publisher: Springer International Publishing
Keywords: Chlorthalidone
Hydrochlorothiazide
Published in: Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-75351-z

At a glance: The STEP trials

Springer Medicine

Chlorthalidone, hydrochlorothiazide cardiovascular outcomes and safety

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Etanercept

Azathioprine/infliximab

Aciclovir

Colecalciferol

Infliximab

Multiple drugs